[HTML][HTML] Mitochondrial dysfunction in Alzheimer's disease and the rationale for bioenergetics based therapies

IG Onyango, J Dennis, SM Khan - Aging and disease, 2016 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is a debilitating neurodegenerative disorder characterized by the
progressive loss of cholinergic neurons, leading to the onset of severe behavioral, motor …

[HTML][HTML] Oxidative stress and cognitive decline: the neuroprotective role of natural antioxidants

F Franzoni, G Scarfò, S Guidotti, J Fusi… - Frontiers in …, 2021 - frontiersin.org
Free-radicals (Oxygen and Nitrogen species) are formed in mitochondria during the
oxidative phosphorylation. Their high reactivity, due to not-engaged electrons, leads to an …

[HTML][HTML] Antioxidant intervention to improve cognition in the aging brain: the example of hydroxytyrosol and resveratrol

S Terracina, C Petrella, S Francati, M Lucarelli… - International Journal of …, 2022 - mdpi.com
Both physiological and pathological aging processes induce brain alterations especially
affecting the speed of processing, working memory, conceptual reasoning and executive …

Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease

G Aliev, M Priyadarshini, VP Reddy… - Current medicinal …, 2014 - ingentaconnect.com
Mitochondrial dysfunction plausibly underlies the aging-associated brain degeneration.
Mitochondria play a pivotal role in cellular bioenergetics and cell-survival. Oxidative stress …

Effect of natural exogenous antioxidants on aging and on neurodegenerative diseases

C Guerra-Araiza, AL Álvarez-Mejía… - Free Radical …, 2013 - Taylor & Francis
Aging and neurodegenerative diseases share oxidative stress cell damage and depletion of
endogenous antioxidants as mechanisms of injury, phenomena that are occurring at …

[HTML][HTML] Mitochondrial dysfunction as a driver of cognitive impairment in Alzheimer's disease

C Sharma, S Kim, Y Nam, UJ Jung, SR Kim - International Journal of …, 2021 - mdpi.com
Alzheimer's disease (AD) is the most frequent cause of age-related neurodegeneration and
cognitive impairment, and there are currently no broadly effective therapies. The underlying …

[HTML][HTML] Prevention of cognitive decline in Alzheimer's disease by novel antioxidative supplements

K Tadokoro, Y Ohta, H Inufusa, AFN Loon… - International journal of …, 2020 - mdpi.com
Oxidative stress plays a crucial role in Alzheimer's disease (AD) from its prodromal stage of
mild cognitive impairment. There is an interplay between oxidative stress and the amyloid β …

[HTML][HTML] Personalized medicine in mitochondrial health and disease: molecular basis of therapeutic approaches based on nutritional supplements and their analogs

V Tragni, G Primiano, A Tummolo, L Cafferati Beltrame… - Molecules, 2022 - mdpi.com
Mitochondrial diseases (MDs) may result from mutations affecting nuclear or mitochondrial
genes, encoding mitochondrial proteins, or non-protein-coding mitochondrial RNA. Despite …

Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities

JM Perez Ortiz, RH Swerdlow - British journal of pharmacology, 2019 - Wiley Online Library
Dysfunction of cell bioenergetics is a common feature of neurodegenerative diseases, the
most common of which is Alzheimer's disease (AD). Disrupted energy utilization implicates …

Mitochondrial inhibition and oxidative stress: reciprocating players in neurodegeneration

GD Zeevalk, LP Bernard, C Song, M Gluck… - Antioxidants & redox …, 2005 - liebertpub.com
Although the etiology for many neurodegenerative diseases is unknown, the common
findings of mitochondrial defects and oxidative damage posit these events as contributing …